Connecticut-based IMS Health Inc. has hired investment bank JP Morgan Chase & Co. Inc. to lead its proposed initial public offering. The IPO could value the private equity-owned healthcare information company at close to $10 billion, sources told Reuters.

According to the report, TPG Capital, Canada Pension Plan Investment Board (CPPIB) and Leonard Green & Parters LP (LPG) chose JPMorgan as the lead underwriter after interviewing investment banks late last week. TPG, CPPIB and LPG took IMS private for $5.2 billion, including debt, in 2010.

Morgan Stanley and Goldman Sachs Group would also lead the offering. Reuters, citing sources, said that IMS' listing is planned for 2014.

IMS' private equity owners could also explore an outright sale of the company. A public offering, however, is a more likely outcome, the sources said.

IMS Health provides prescription data to the pharmaceutical industry, medical device makers, government agencies and other companies in the healthcare sector. It has over 5,000 clients and operates in over 100 countries, Reuters wrote.